Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients. Εκτύπωση
Συντάχθηκε απο τον/την gkatsaros   
Δευτέρα, 08 Φεβρουάριος 2010 12:24

Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.

Papanas N, Tziakas D, Chalikias G, Floros D, Trypsianis G, Papadopoulou E, Kortsaris A, Symeonidis G, Souliou E, Maltezos E, Hatseras D.

Diabetes Metab. 2006 Sep;32(4):344-9.PMID: 16977262 [PubMed - indexed for MEDLINE]Related articlesFree article